 |
市場調查報告書
商品編碼
1777258
缺血性中風手術的全球市場:手術類型·產品類型·終端用戶·各地區 (～2035年)Global Ischemic Stroke Surgery Market Research Report by Type of Surgery, by Product Type, by End-User, and by Region Industry Forecast till 2035 |
||||||
價格
全球缺血性中風手術市場預計將從 2021 年的 22.9116 億美元成長至 2035 年底的 72.6615 億美元，複合年增長率為 8.70%。
缺血性中風手術是一種清除血栓、恢復腦血流的醫療手段，可以最大限度地減少腦損傷，提高急性缺血性中風患者的康復幾率。
缺乏運動和不良的生活習慣正在推動全球缺血性中風手術市場的需求。先進手術技術和設備的引入正在改善治療效果，越來越多的患者選擇微創手術來加速復原。
然而，醫療基礎設施不足和熟練醫務人員的短缺阻礙了該領域的發展。然而，隨著研發和投資的增加，缺血性中風手術市場正在尋找新的發展途徑。
區域分析
由於中風病例數量眾多以及血管內血栓切除術等尖端技術的廣泛應用，北美市場持續快速擴張。推動市場成長的因素包括老齡人口成長、認知度提高以及技術進步。
新的研究和血栓切除術等成功的治療方法正在推動歐洲市場的成長。由於對醫療創新的大力支持，該地區的卒中治療效果正在改善。
隨著各國政府加大研究和醫療保健支出，亞太市場正快速擴張。在韓國、日本和印度等國家，新的治療方法越來越普及，幫助患者復原。
在拉丁美洲、中東和非洲，中風相關疾病的發生率呈上升趨勢，推動了對手術的需求。更好的醫療基礎設施和健康計劃支持這些地區全球市場的成長。
本報告研究了全球缺血性中風手術市場，並提供了市場定義和概述、影響市場成長的各種因素分析、市場規模趨勢和預測、按各個細分市場、地區和主要國家/地區進行的細分、競爭格局以及主要公司的概況。
目錄
第1章 摘要整理
第2章 市場概要
第3章 調查手法
第4章 市場動態
- 促進因素
- 缺乏運動和久坐不動的生活方式日益增多
- 先進科技產品的採用與推出
- 微創手術需求不斷成長
- 限制因素
- 醫療設施短缺
- 熟練專業人員短缺
- 機遇
- 研發活動與投資
第5章 市場要素分析
- 價值鏈分析
- 波特的五力分析
- COVID-19對全球缺血性中風手術市場帶來的影響
- 流行病學分析
- 法規分析/醫療制度
第6章 全球缺血性中風手術市場:手術類別
- 概要
- 血栓消除術
- 血管再生手術
- 頸動脈內薄膜切除術
- 血管成形術
- 其他
第7章 全球缺血性中風手術市場:各產品類型
- 概要
- 導管
- 吸引系統
- 導管導引線
- 微導管
- 其他
第8章 全球缺血性中風手術市場:各終端用戶
- 概要
- 醫院·診療所
- 門診病人手術中心
- 其他
第9章 全球缺血性中風手術市場:各地區
- 概要
- 北美
- 美國
- 加拿大
- 歐洲
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 其他
- 亞太地區
- 日本
- 中國
- 印度
- 澳洲
- 韓國
- 其他
- 其他地區
- 中東
- 非洲
- 南美
第10章 競爭情形
- 概要
- 市場佔有率分析
- 競爭基準
- 全球缺血性中風手術市場的關鍵成長策略
- 全球缺血性中風手術發展數量排名靠前的頂級公司市場
- 主要的開發分析
- 主要的展開·成長策略
- 財務矩陣
第11章 企業簡介
- MEDTRONIC PLC
- ABBOTT LABORATORIES
- BOSTON SCIENTIFIC CORPORATION
- CORDIS CORPORATION
- KONINKLIJKE PHILIPS N.V
- STRYKER
- IMPERATIVE CARE
- JOHNSON & JOHNSON SERVICES, INC.
- PENUMBRA, INC.
- PHENOXYHENOX GMBH
第12章 附錄
Product Code: MRFR/HC/9493-CR
Global Ischemic Stroke Surgery Market Research Report by Type of Surgery (Thrombectomy, Revascularization Surgery, Carotid Endarterectomy, Angioplasty, Others), by Product Type (Catheters, Aspiration System, Guidewire, Microcatheter, Others), by End-User (Hospitals and Clinics, Ambulatory Surgical Centers, Others), and by Region (North America, Europe, Asia Pacific, Rest of the World) Industry Forecast till 2035
Industry Overview
The global ischemic stroke surgery market reached USD 2,291.16 million in 2021 and is projected to achieve USD 7,266.15 million with a CAGR of 8.70% by the end of 2035. Ischemic stroke surgery is a medical procedure used to remove blood clots and restore blood flow to the brain. It helps reduce brain damage and improves recovery chances in patients suffering from acute ischemic stroke.
An increase in physical inactivity and poor lifestyle choices is pushing the demand in the global ischemic stroke surgery market. Advanced surgical methods and tools are making treatments more effective. Patients are also choosing less invasive procedures for quicker recovery.
The presence of limited medical infrastructure and a lack of experienced professionals is slowing the progress of the global ischemic stroke surgery industry. Still, with more research and investment, the ischemic stroke surgery market is finding new paths for development.
Industry Segmentations
In terms of product type, the global market is divided into catheters, aspiration systems, guidewires, microcatheters, and others.
Based on the type of surgery, the global ischemic stroke surgery market is classified into Thrombectomy, Revascularization Surgery, Carotid Endarterectomy, Angioplasty, and others.
The global ischemic stroke surgery market is segmented based on the end-users, including hospitals and clinics, ambulatory surgical centers, and others.
Regional Analysis
The ischemic stroke surgery market is still expanding rapidly in North America due to a large number of stroke cases and rising utilization of cutting-edge techniques like endovascular thrombectomy. An increasing senior population, more awareness, and technological advancements are all driving market expansion.
New research and successful treatments like thrombectomy are driving the growth of the ischemic stroke surgery market in Europe. The region's stroke treatment results are improving because of strong support for healthcare innovation.
The ischemic stroke surgery market is broadening quickly in the Asia-Pacific as governments increase their spending on research and healthcare. New treatments are becoming more widely available in nations like South Korea, Japan, and India, which is helping patients recover.
Latin America, the Middle East, and Africa are experiencing a rise in stroke-related illnesses, creating a higher demand for surgery. Better medical infrastructure and health programs are helping these regions grow in the global market.
Key Players
Major players in the global ischemic stroke surgery market are Medtronic Plc, Abbott Laboratories, Boston Scientific Corporation, Cordis Corporation, Johnson & Johnson Services Inc., Koninklijke Philips N.V., Stryker, Imperative Care, Penumbra, Inc., and Phenox GmbH.
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
- 1.1 OVERVIEW
2 MARKET INTRODUCTION
- 2.1 DEFINITION
- 2.2 SCOPE OF THE STUDY
- 2.3 RESEARCH OBJECTIVE
- 2.4 MARKET STRUCTURE
- 2.5 ASSUMPTIONS & LIMITATIONS
3 RESEARCH METHODOLOGY
- 3.1 DATA MINING
- 3.2 SECONDARY RESEARCH
- 3.3 PRIMARY RESEARCH
- 3.4 BREAKDOWN OF PRIMARY RESPONDENTS
- 3.5 FORECASTING TECHNIQUES
- 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
- 3.6.1 BOTTOM-UP APPROACH
- 3.6.2 TOP-DOWN APPROACH
- 3.7 DATA TRIANGULATION
- 3.8 VALIDATION
4 MARKET DYNAMICS
- 4.1 OVERVIEW
- 4.2 DRIVERS
- 4.2.1 RISE IN PHYSICAL INACTIVITY AND SEDENTARY LIFESTYLES
- 4.2.2 ADOPTION AND LAUNCH OF TECHNOLOGICALLY ADVANCED PRODUCTS
- 4.2.3 RISING DEMAND FOR MINIMALLY INVASIVE PROCEDURES
- 4.3 RESTRAINTS
- 4.3.1 LACK OF MEDICAL FACILITIES
- 4.3.2 SHORTAGE OF SKILLED PROFESSIONALS
- 4.4 OPPORTUNITIES
- 4.4.1 R&D ACTIVITIES AND INVESTMENTS
5 MARKET FACTOR ANALYSIS
- 5.1 VALUE CHAIN ANALYSIS
- 5.1.1 R&D
- 5.1.2 MANUFACTURING
- 5.1.3 DISTRIBUTION AND SALES
- 5.1.4 POST-SALES MONITORING
- 5.2 PORTER'S FIVE FORCES MODEL
- 5.2.1 THREAT OF NEW ENTRANTS
- 5.2.2 BARGAINING POWER OF SUPPLIERS
- 5.2.3 THREAT OF SUBSTITUTES
- 5.2.4 BARGAINING POWER OF BUYERS
- 5.2.5 INTENSITY OF RIVALRY
- 5.3 IMPACT OF COVID-19 ON THE GLOBAL ISCHEMIC STROKE SURGERY MARKET
- 5.3.1 IMPACT ON SUPPLY CHAIN
- 5.3.2 IMPACT ON PRODUCTION
- 5.3.3 IMPACT ON DEMAND
- 5.4 EPIDEMIOLOGY ANALYSIS
- 5.4.1 INCIDENCE & PREVALENCE
- 5.4.2 NUMBER OF PROCEDURES FOR THROMBECTOMY
- 5.5 REGULATORY ANALYSIS/HEALTHCARE SYSTEM
6 GLOBAL ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY
- 6.1 OVERVIEW
- 6.2 THROMBECTOMY
- 6.3 REVASCULARIZATION SURGERY
- 6.4 CAROTID ENDARTERECTOMY
- 6.5 ANGIOPLASTY
- 6.6 OTHERS
7 GLOBAL ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE
- 7.1 OVERVIEW
- 7.2 CATHETER
- 7.3 ASPIRATION SYSTEM
- 7.4 GUIDEWIRE
- 7.5 MICROCATHETER
- 7.6 OTHERS
8 GLOBAL ISCHEMIC STROKE SURGERY MARKET, BY END USER
- 8.1 OVERVIEW
- 8.2 HOSPITALS AND CLINICS
- 8.3 AMBUATORY SURGICAL CENTRES
- 8.4 OTHERS
9 GLOBAL ISCHEMIC STROKE SURGERY MARKET, BY REGION
- 9.1 OVERVIEW
- 9.2 NORTH AMERICA
- 9.2.1 US
- 9.2.2 CANADA
- 9.3 EUROPE
- 9.3.1 GERMANY
- 9.3.2 UK
- 9.3.3 FRANCE
- 9.3.4 ITALY
- 9.3.5 SPAIN
- 9.3.6 REST OF EUROPE
- 9.4 ASIA PACIFIC
- 9.4.1 JAPAN
- 9.4.2 CHINA
- 9.4.3 INDIA
- 9.4.4 AUSTRALIA
- 9.4.5 SOUTH KOREA
- 9.4.6 REST OF ASIA PACIFIC
- 9.5 REST OF THE WORLD
- 9.5.1 MIDDLE EAST
- 9.5.2 AFRICA
- 9.5.3 LATIN AMERICA
10 COMPETITIVE LANDSCAPE
- 10.1 OVERVIEW
- 10.2 MARKET SHARE ANAYISIS
- 10.3 COMPETITIVE BENCHMARKING
- 10.4 MAJOR GROWTH STRATEGY IN THE GLOBAL ISCHEMIC STROKE SURGERY MARKET
- 10.5 THE LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL ISCHEMIC STROKE SURGERY MARKET
- 10.6 KEY DEVELOPMENT ANALYSIS
- 10.7 KEY DEVELOPMENTS & GROWTH STRATEGIES
- 10.7.1 MERGER & ACQUISITIONS
- 10.7.2 AGREEMENT/MARKETING STRATEGIES
- 10.8 FINANCIAL MATRIX
- 10.8.1 SALES (USD MILLION), 2021
- 10.8.2 RESEARCH & DEVELOPMENT EXPENDITURE (USD MILLION), 2021
11 COMPANY PROFILES
- 11.1 MEDTRONIC PLC
- 11.1.1 COMPANY OVERVIEW
- 11.1.2 FINANCIAL OVERVIEW
- 11.1.3 PRODUCTS/SERVICES OFFERED
- 11.1.4 KEY DEVELOPMENTS
- 11.1.5 SWOT ANALYSIS
- 11.1.6 KEY STRATEGIES
- 11.2 ABBOTT LABORATORIES
- 11.2.1 COMPANY OVERVIEW
- 11.2.2 FINANCIAL OVERVIEW
- 11.2.3 PRODUCTS/SERVICES OFFERED
- 11.2.4 KEY DEVELOPMENTS
- 11.2.5 KEY STRATEGIES
- 11.3 BOSTON SCIENTIFIC CORPORATION
- 11.3.1 COMPANY OVERVIEW
- 11.3.2 FINANCIAL OVERVIEW
- 11.3.3 PRODUCTS/SERVICES OFFERED
- 11.3.4 KEY DEVELOPMENTS
- 11.3.5 KEY STRATEGIES
- 11.4 CORDIS CORPORATION
- 11.4.1 COMPANY OVERVIEW
- 11.4.2 FINANCIAL OVERVIEW
- 11.4.3 PRODUCTS/SERVICES OFFERED
- 11.4.4 KEY DEVELOPMENTS
- 11.4.5 KEY STRATEGIES
- 11.5 KONINKLIJKE PHILIPS N.V
- 11.5.1 COMPANY OVERVIEW
- 11.5.2 FINANCIAL OVERVIEW
- 11.5.3 PRODUCTS/SERVICES OFFERED
- 11.5.4 KEY DEVELOPMENTS
- 11.5.5 SWOT ANALYSIS
- 11.5.6 KEY STRATEGIES
- 11.6 STRYKER
- 11.6.1 COMPANY OVERVIEW
- 11.6.2 FINANCIAL OVERVIEW
- 11.6.3 PRODUCTS OFFERED
- 11.6.4 KEY DEVELOPMENTS
- 11.6.5 SWOT ANALYSIS
1 1.6.6 KEY STRATEGIES
- 11.7 IMPERATIVE CARE
- 11.7.1 COMPANY OVERVIEW
- 11.7.2 FINANCIAL OVERVIEW
- 11.7.3 PRODUCTS OFFERED
- 11.7.4 KEY DEVELOPMENTS
- 11.7.5 KEY STRATEGIES
- 11.8 JOHNSON & JOHNSON SERVICES, INC.
- 11.8.1 COMPANY OVERVIEWS
- 11.8.2 FINANCIAL OVERVIEW
- 11.8.3 PRODUCTS OFFERED
- 11.8.4 KEY DEVELOPMENTS
- 11.8.5 SWOT ANALYSIS
- 11.8.6 KEY STRATEGIES
- 11.9 PENUMBRA, INC.
- 11.9.1 COMPANY OVERVIEW
- 11.9.2 FINANCIAL OVERVIEW
- 11.9.3 PRODUCTS OFFERED
- 11.9.4 KEY DEVELOPMENTS
- 11.9.5 SWOT ANALYSIS
- 11.9.6 KEY STRATEGIES
- 11.10 PHENOXYHENOX GMBH
- 11.10.1 COMPANY OVERVIEW
- 11.10.2 FINANCIAL OVERVIEW
- 11.10.3 PRODUCTS OFFERED
- 11.10.4 KEY DEVELOPMENTS
- 11.10.5 KEY STRATEGIES
12 APPENDIX
- 12.1 REFERENCES
- 12.2 RELATED REPORTS
LIST OF TABLES
- TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS
- TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
- TABLE 3 NUMBER OF PROCEDURES FOR THROMBECTOMY, BY REGION (2021)
- TABLE 4 NUMBER OF PROCEDURES FOR THROMBECTOMY, BY COUNTRY (2021)
- TABLE 5 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
- TABLE 6 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR THROMBECTOMY, BY REGION, 2018-2035 (USD MILLION)
- TABLE 7 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR REVASCULARIZATION SURGERY, BY REGION, 2018-2035 (USD MILLION)
- TABLE 8 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR CAROTID ENDARTERECTOMY, BY REGION, 2018-2035 (USD MILLION)
- TABLE 9 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR ANGIOPLASTY, BY REGION, 2018-2035 (USD MILLION)
- TABLE 10 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR OTHERS, BY REGION, 2018-2035 (USD MILLION)
- TABLE 11 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
- TABLE 12 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR CATHETER, BY REGION, 2018-2035 (USD MILLION)
- TABLE 13 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR ASPIRATION SYSTEM, BY REGION, 2018-2035 (USD MILLION)
- TABLE 14 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR GUIDEWIRE, BY REGION, 2018-2035 (USD MILLION)
- TABLE 15 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR MICROCATHETER, BY REGION, 2018-2035 (USD MILLION)
- TABLE 16 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR OTHERS, BY REGION, 2018-2035 (USD MILLION)
- TABLE 17 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
- TABLE 18 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR HOSPITALS & CLINICS, BY REGION, 2018-2035 (USD MILLION)
- TABLE 19 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR AMBULATORY SURGERY CENTRES, BY REGION, 2018-2035 (USD MILLION)
- TABLE 20 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR OTHERS BY REGION, 2018-2035 (USD MILLION)
- TABLE 21 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, BY REGION, 2018-2035 (USD MILLION)
- TABLE 22 NORTH AMERICA: ISCHEMIC STROKE SURGERY MARKET, BY COUNTRY, 2018-2035 (USD MILLION)
- TABLE 23 NORTH AMERICA: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
- TABLE 24 NORTH AMERICA: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
- TABLE 25 NORTH AMERICA: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
- TABLE 26 US: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
- TABLE 27 US: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
- TABLE 28 US: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
- TABLE 29 CANADA: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
- TABLE 30 CANADA: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
- TABLE 31 CANADA: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
- TABLE 32 EUROPE: ISCHEMIC STROKE SURGERY MARKET, BY COUNTRY, 2018-2035 (USD MILLION)
- TABLE 33 EUROPE: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
- TABLE 34 EUROPE: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
- TABLE 35 EUROPE: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
- TABLE 36 GERMANY: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
- TABLE 37 GERMANY: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
- TABLE 38 GERMANY: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
- TABLE 39 UK: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
- TABLE 40 UK: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
- TABLE 41 UK: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
- TABLE 42 FRANCE: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
- TABLE 43 FRANCE: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
- TABLE 44 FRANCE: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
- TABLE 45 ITALY: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
- TABLE 46 ITALY: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
- TABLE 47 ITALY: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
- TABLE 48 SPAIN: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
- TABLE 49 SPAIN: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
- TABLE 50 SPAIN: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
- TABLE 51 REST OF EUROPE: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
- TABLE 52 REST OF EUROPE: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
- TABLE 53 REST OF EUROPE: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
- TABLE 54 ASIA PACIFIC: ISCHEMIC STROKE SURGERY MARKET, BY COUNTRY, 2018-2035 (USD MILLION)
- TABLE 55 ASIA-PACIFIC: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
- TABLE 56 ASIA-PACIFIC: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
- TABLE 57 ASIA-PACIFIC: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
- TABLE 58 JAPAN: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
- TABLE 59 JAPAN: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
- TABLE 60 JAPAN: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
- TABLE 61 CHINA: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
- TABLE 62 CHINA: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
- TABLE 63 CHINA: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
- TABLE 64 INDIA: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
- TABLE 65 INDIA: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
- TABLE 66 INDIA: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
- TABLE 67 AUSTRALIA: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
- TABLE 68 AUSTRALIA: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
- TABLE 69 AUSTRALIA: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
- TABLE 70 SOUTH KOREA: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
- TABLE 71 SOUTH KOREA: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
- TABLE 72 SOUTH KOREA: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
- TABLE 73 REST OF ASIA-PACIFIC: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
- TABLE 74 REST OF ASIA-PACIFIC: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
- TABLE 75 REST OF ASIA-PACIFIC: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
- TABLE 76 REST OF THE WORLD: ISCHEMIC STROKE SURGERY MARKET, BY REGION, 2018-2035(USD MILLION)
- TABLE 77 REST OF THE WORLD: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
- TABLE 78 REST OF THE WORLD: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
- TABLE 79 REST OF THE WORLD: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
- TABLE 80 MIDDLE EAST: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
- TABLE 81 MIDDLE EAST: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
- TABLE 82 MIDDLE EAST: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
- TABLE 83 AFRICA: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
- TABLE 84 AFRICA: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
- TABLE 85 AFRICA: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
- TABLE 86 LATIN AMERICA: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
- TABLE 87 LATIN AMERICA: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
- TABLE 88 LATIN AMERICA: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
- TABLE 89 MAJOR PLAYERS IN THE GLOBAL ISCHEMIC STROKE SURGERY MARKET
- TABLE 90 MOST ACTIVE PLAYERS IN THE GLOBAL ISCHEMIC STROKE SURGERY MARKET
- TABLE 91 PRODUCT LAUNCH/PRODUCT APPROVAL
- TABLE 92 MERGER & ACQUISITIONS
- TABLE 93 AGREEMENT/MARKETING STRATEGIES
- TABLE 94 MEDTRONIC PLC: PRODUCTS OFFERED
- TABLE 95 ABBOTT LABORATORIES: PRODUCTS/SERVICES OFFERED
- TABLE 96 ABBOTT LABORATORIES: KEY DEVELOPMENTS
- TABLE 97 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED
- TABLE 98 CORDIS CORPORATION: PRODUCTS/SERVICES OFFERED
- TABLE 99 KONINKLIJKE PHILIPS N.V .: PRODUCTS/SERVICES OFFERED
- TABLE 100 STRYKER: PRODUCTS OFFERED
- TABLE 101 STRYKER: KEY DEVELOPMENTS
- TABLE 102 IMPERATIVE CARE: PRODUCTS OFFERED
- TABLE 103 IMPERATIVE CARE: KEY DEVELOPMENTS
- TABLE 104 JOHNSON & JOHNSON SERVICES, INC.: PRODUCTS OFFERED
- TABLE 105 JOHNSON & JOHNSON SERVICES, INC.: KEY DEVELOPMENTS
- TABLE 106 PENUMBRA, INC.: PRODUCTS OFFERED
- TABLE 107 PENUMBRA, INC.: KEY DEVELOPMENTS
- TABLE 108 PHENOX GMBH: PRODUCTS OFFERED
- TABLE 109 PHENOX GMBH: KEY DEVELOPMENTS
LIST OF FIGURES
- FIGURE 1 MARKET SYNOPSIS
- FIGURE 2 GLOBAL ISCHEMIC STROKE SURGERY MARKET
- FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES
- FIGURE 4 MARKET DYNAMICS: GLOBAL ISCHEMIC STROKE SURGERY MARKET
- FIGURE 5 DRIVERS: IMPACT ANALYSIS
- FIGURE 6 RESTRAINT: IMPACT ANALYSIS
- FIGURE 7 VALUE CHAIN ANALYSIS: GLOBAL ISCHEMIC STROKE SURGERY MARKET
- FIGURE 8 PORTER'S FIVE FORCES ANALYSIS: GLOBAL ISCHEMIC STROKE MARKET
- FIGURE 1 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2021 & 2035 (USD MILLION)
- FIGURE 2 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2021 & 2035 (USD MILLION)
- FIGURE 3 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2021 & 2035 (USD MILLION)
- FIGURE 4 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, BY REGION 2021 & 2035 (USD MILLION)
- FIGURE 5 GLOBAL: ISCHEMIC STROKE SURGERY MARKET SHARE (%), BY REGION,
- FIGURE 6 NORTH AMERICA: ISCHEMIC STROKE SURGERY MARKET SHARE (%), BY COUNTRY
- FIGURE 7 NORTH AMERICA: ISCHEMIC STROKE SURGERY MARKET, BY COUNTRY 2021 & 2035 (USD MILLION)
- FIGURE 8 EUROPE: ISCHEMIC STROKE SURGERY MARKET SHARE (%), BY COUNTRY
- FIGURE 9 EUROPE: ISCHEMIC STROKE SURGERY MARKET, BY COUNTRY 2021 & 2035 (USD MILLION)
- FIGURE 10 ASIA PACIFIC: ISCHEMIC STROKE SURGERY MARKET SHARE (%), BY COUNTRY,
- FIGURE 11 ASIA PACIFIC ISCHEMIC STROKE SURGERY MARKET SHARE, BY COUNTRY 2021 & 2035 (USD MILLION)
- FIGURE 12 REST OF THE WORLD: ISCHEMIC STROKE SURGERY MARKET SHARE (%), BY REGION,
- FIGURE 13 REST OF THE WORLD ISCHEMIC STROKE SURGERY MARKET SHARE, BY REGION 2021 & 2035 (USD MILLION)
- FIGURE 14 MAJOR MANUFACTURERS MARKET SHARE (%) ANALYSIS,
- FIGURE 15 BENCHMARKING OF MAJOR COMPETITORS
- FIGURE 16 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL ISCHEMIC STROKE SURGERY MARKET
- FIGURE 17 GLOBAL ISCHEMIC STROKE SURGERY MARKET: COMPETITIVE LANDSCAPE
- FIGURE 18 SALES (USD MILLION),
- FIGURE 19 RESEARCH & DEVELOPMENT EXPENDITURE
- FIGURE 20 MEDTRONIC PLC: FINANCIAL OVERVIEW SNAPSHOT
- FIGURE 21 MEDTRONIC PLC: SWOT ANALYSIS
- FIGURE 22 ABBOTT LABORATORIES: FINANCIAL OVERVIEW SNAPSHOT
- FIGURE 23 BOSTON SCIENTIFIC CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
- FIGURE 24 KONINKLIJKE PHILIPS N.V.: FINANCIAL OVERVIEW SNAPSHOT
- FIGURE 25 KONINKLIJKE PHILIPS N.V.: SWOT ANALYSIS
- FIGURE 26 STRYKER: FINANCIAL OVERVIEW SNAPSHOT
- FIGURE 27 STRYKER: SWOT ANALYSIS
- FIGURE 28 JOHNSON & JOHNSON SERVICES, INC.: FINANCIAL OVERVIEW SNAPSHOT
- FIGURE 29 JOHNSON & JOHNSON SERVICES INC.: SWOT ANALYSIS
- FIGURE 30 PENUMBRA, INC.: FINANCIAL OVERVIEW SNAPSHOT
- FIGURE 31 PENUMBRA, INC.: SWOT ANALYSIS
